_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage-preview-1.jpg "AML17 trial update: FLT3-ITD mutation and daunorubicin dosage from flt3 itd mutation positive Video Screenshot Preview 1")
Gallery_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage-preview-3.jpg "AML17 trial update: FLT3-ITD mutation and daunorubicin dosage from flt3 itd mutation positive Video Screenshot Preview 3")
Gallery_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage-preview-hqdefault.jpg "AML17 trial update: FLT3-ITD mutation and daunorubicin dosage from flt3 itd mutation positive Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 54 seconds
👁 View: 155 times
Play Audio:👁 View: 155 times
Description:
VJHemOnc – Video Journal of Hematology u0026 HemOnc
VJHemOnc – Video Journal of Hematology u0026 HemOnc
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_what-is-flt3-positive-aml-what-is-gilteritinib-aml.webp "HealthTree University for Blood Cancers")
_best-treatment-strategy-for-flt3-itd-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_quizartinib-for-flt3-itd-positive-aml-after-second-line-chemo-or-stem-cell-transplant.webp "Research suggests that a new targeted therapy, quizartinib, may be a safe and effective option to treat a subset of patients with treatment-resistant acute myeloid leukaemia (AML), whose leukaemia has the FLT3-ITD mutation.nnQuizartinib is the first and only single-agent drug that has produced a clinical benefit in AML patients with this deadly mutation who have failed previous therapy.nnThe number of patients bridged to a stem cell transplant was very significant. Dr Levis and his colleagues pl")
⏲ 3 min 26 sec ✓ 16-Jan-2018
_significance-of-flt3-mutations-in-aml.webp "OncLiveTV")
_quizartinib-advances-overall-survival-in-acute-myeloid-leukaemia-patients.webp "Dr Harry Erba speaks to ecancer at the EHA 2022 meeting about quizartinib improving the overall survival in adult patients with FLT3-ITD+ acutenmyeloid leukaemia.nn Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults, and approximately 25% of all newly diagnosed cases carry the FLT3-internal tandem duplication (ITD) gene mutation.nnThe results showed that the addition of quizartinib significantly improved overall survival compared with standard induction and consolidation")
⏲ 2 min 14 sec ✓ 11-Jun-2022
_what-is-flt3-mutated-acute-myeloid-leukemia.webp "Patient Empowerment Network")
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.webp "Targeted Oncology")
_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
Related Video Searches
Back to Search
Search Videos
Recent Searches
×
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
_what-is-flt3-positive-aml-what-is-gilteritinib-aml.jpg)
_best-treatment-strategy-for-flt3-itd-aml.jpg)
_quizartinib-for-flt3-itd-positive-aml-after-second-line-chemo-or-stem-cell-transplant.jpg)
_significance-of-flt3-mutations-in-aml.jpg)
_quizartinib-advances-overall-survival-in-acute-myeloid-leukaemia-patients.jpg)
_what-is-flt3-mutated-acute-myeloid-leukemia.jpg)
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.jpg)
_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml.jpg)
❮❯
1 / 12
2 / 12
3 / 12
4 / 12
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
5 / 12
6 / 12
7 / 12
8 / 12
9 / 12
10 / 12
11 / 12
12 / 12
![[+]](/images/menu.gif){kind=small}